Top NIH grants, grantees in 2007

It's the end of the year, so time to count the number of pennies the NIH has doled out in the last 12 months. Genetic Engineering and Biotechnology News linkurl:published a list;http://www.genengnews.com/news/bnitem.aspx?name=28380062 of the top 20 PIs of the year, and Barton F. Haynes at Duke University ($46,482,429) sits at the top of that pyramid. The best-funded institutions were Johns Hopkins University ($566,516,255) and the University of Pennsylvania ($434,874,723). The list is some

Written byAlison McCook
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
It's the end of the year, so time to count the number of pennies the NIH has doled out in the last 12 months. Genetic Engineering and Biotechnology News linkurl:published a list;http://www.genengnews.com/news/bnitem.aspx?name=28380062 of the top 20 PIs of the year, and Barton F. Haynes at Duke University ($46,482,429) sits at the top of that pyramid. The best-funded institutions were Johns Hopkins University ($566,516,255) and the University of Pennsylvania ($434,874,723). The list is somewhat deceiving, since Harvard doesn't make the top 25 because its independent hospitals are not included in the institution's total. It deserves to be there: In 2004, Harvard and its five domestic hospitals linkurl:brought in a total;http://www.the-scientist.com/article/display/24101/ of $852 million in extramural awards. The linkurl:source;http://www.nihsales.com/ of the 2007 information is NIH Sales, which analyzes the agency's funding.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies